RCT
Published: Nov 2009
ACE Report #5098
Ace Report Cover Tumour

MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group

Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566

Contributing Authors: Z Chen RB Womer MD Krailo JH Healey AJ Chou ES Kleinerman DL Betcher Conrad EU ML Nieder MA Weiner RJ Wells PA Meyers Children's Oncology Group

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.